Concerns Arise Over New Vaccine Review Panel for Children
June 26, 2025 - 14:51
Health experts are expressing apprehension regarding a newly established panel tasked with reviewing long-approved vaccines for children in the United States. This panel, which plays a crucial role in determining the vaccination schedule and recommendations, is under scrutiny for its potential impact on public health.
The panel's focus on revisiting established vaccines raises questions about the motivations behind such reviews, especially considering the extensive research and data supporting the safety and efficacy of these immunizations. Critics worry that this could lead to unnecessary hesitancy among parents, who may already be uncertain about vaccine safety due to misinformation.
Public health officials emphasize the importance of maintaining trust in vaccines, which have historically played a vital role in preventing serious diseases in children. As the panel begins its work, the medical community is urging that any decisions made should be based on solid scientific evidence to ensure the continued protection of children's health across the nation.
MORE NEWS
May 13, 2026 - 19:53
From Zambia to Harvard: How Chimba Sanga Is Fighting HIV and TB With New SkillsChimba Sanga, a physician and public health leader from Zambia, is bringing his Harvard training back home to tackle two of the country`s deadliest diseases. Sanga, currently a Master of Public...
May 13, 2026 - 01:07
AP report: Marty Makary resigning as Trump's FDA chiefMarty Makary is resigning as head of the Food and Drug Administration, according to an Associated Press report. His departure comes after a turbulent tenure marked by deep internal discord and a...
May 12, 2026 - 10:26
Shortage of beds, staff force Michigan kids out of state for mental health treatmentMichigan children facing severe mental health crises are increasingly being transported out of state for treatment, sometimes traveling thousands of miles away from their families. The root cause...
May 11, 2026 - 17:47
Medicare’s miss on Alzheimer’s drug spendingFar fewer seniors than expected are taking costly Alzheimer`s drugs, leaving Medicare spending well below earlier government forecasts. The new class of amyloid-targeting treatments, including...